secwatch.observer — SEC 8-K summary
======================================

Issuer:     Panbela Therapeutics, Inc. (—)
CIK:        0001029125
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001437749-24-001758
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Panbela Therapeutics effects 1-for-20 reverse stock split; shares outstanding drop to 480,244
--------------------------------------------------------------------------------

- Reverse split effective Jan 18, 2024; every 20 shares converted into 1 share.
- Post-split estimated shares outstanding: 480,244.
- New CUSIP number for common stock is 69833W404.
- Proportionate adjustments made to equity awards and warrants.
- Number of authorized shares unchanged; no fractional shares issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029125/000143774924001758/0001437749-24-001758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029125/000143774924001758/pbla20240118_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer